246 related articles for article (PubMed ID: 19131562)
1. Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes.
Duale N; Bjellaas T; Alexander J; Becher G; Haugen M; Paulsen JE; Frandsen H; Olesen PT; Brunborg G
Toxicol Sci; 2009 Mar; 108(1):90-9. PubMed ID: 19131562
[TBL] [Abstract][Full Text] [Related]
2. The modifying effect of CYP2E1, GST, and mEH genotypes on the formation of hemoglobin adducts of acrylamide and glycidamide in workers exposed to acrylamide.
Huang YF; Chiang SY; Liou SH; Chen ML; Chen MF; Uang SN; Wu KY
Toxicol Lett; 2012 Nov; 215(2):92-9. PubMed ID: 23069881
[TBL] [Abstract][Full Text] [Related]
3. Cord blood acrylamide levels and birth size, and interactions with genetic variants in acrylamide-metabolising genes.
Hogervorst J; Vesper HW; Madhloum N; Gyselaers W; Nawrot T
Environ Health; 2021 Apr; 20(1):35. PubMed ID: 33794901
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies of the influence of glutathione transferases and epoxide hydrolase on the detoxification of acrylamide and glycidamide in blood.
Paulsson B; Rannug A; Henderson AP; Golding BT; Törnqvist M; Warholm M
Mutat Res; 2005 Feb; 580(1-2):53-9. PubMed ID: 15668107
[TBL] [Abstract][Full Text] [Related]
5. Association of CYP2E1, GST and mEH genetic polymorphisms with urinary acrylamide metabolites in workers exposed to acrylamide.
Huang YF; Chen ML; Liou SH; Chen MF; Uang SN; Wu KY
Toxicol Lett; 2011 Jun; 203(2):118-26. PubMed ID: 21402133
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism of lysyl oxidase, glutathione S-transferase M1, glutathione-S-transferase T1, and glutathione S-transferase P1 genes as risk factors for lung cancer in Egyptian patients.
El-Deek SEM; Abdel-Ghany SM; Hana RS; Mohamed AAR; El-Melegy NT; Sayed AA
Mol Biol Rep; 2021 May; 48(5):4221-4232. PubMed ID: 34052967
[TBL] [Abstract][Full Text] [Related]
7. Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts.
Ghanayem BI; McDaniel LP; Churchwell MI; Twaddle NC; Snyder R; Fennell TR; Doerge DR
Toxicol Sci; 2005 Dec; 88(2):311-8. PubMed ID: 16141435
[TBL] [Abstract][Full Text] [Related]
8. Combined analysis of EPHX1, GSTP1, GSTM1 and GSTT1 gene polymorphisms in relation to chronic obstructive pulmonary disease risk and lung function impairment.
Lakhdar R; Denden S; Knani J; Leban N; Daimi H; Hassine M; Lefranc G; Chibani JB; Khelil AH
Dis Markers; 2011; 30(5):253-63. PubMed ID: 21734345
[TBL] [Abstract][Full Text] [Related]
9. The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans.
Pellè L; Carlsson H; Cipollini M; Bonotti A; Foddis R; Cristaudo A; Romei C; Elisei R; Gemignani F; Törnqvist M; Landi S
Arch Toxicol; 2018 Jun; 92(6):2137-2140. PubMed ID: 29748789
[TBL] [Abstract][Full Text] [Related]
10. In vitro studies of the influence of certain enzymes on the detoxification of acrylamide and glycidamide in blood.
Paulsson B; Warholm M; Rannug A; Törnqvist M
Adv Exp Med Biol; 2005; 561():127-33. PubMed ID: 16438295
[TBL] [Abstract][Full Text] [Related]
11. Occupational exposure to styrene: modulation of cytogenetic damage and levels of urinary metabolites of styrene by polymorphisms in genes CYP2E1, EPHX1, GSTM1, GSTT1 and GSTP1.
Teixeira JP; Gaspar J; Silva S; Torres J; Silva SN; Azevedo MC; Neves P; Laffon B; Méndez J; Gonçalves C; Mayan O; Farmer PB; Rueff J
Toxicology; 2004 Feb; 195(2-3):231-42. PubMed ID: 14751678
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of Acrylamide: Interindividual and Interspecies Differences as Well as the Application as Biomarkers.
Li D; Wang P; Liu Y; Hu X; Chen F
Curr Drug Metab; 2016; 17(4):317-26. PubMed ID: 26467066
[TBL] [Abstract][Full Text] [Related]
13. In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans.
Doroshyenko O; Fuhr U; Kunz D; Frank D; Kinzig M; Jetter A; Reith Y; Lazar A; Taubert D; Kirchheiner J; Baum M; Eisenbrand G; Berger FI; Bertow D; Berkessel A; Sörgel F; Schömig E; Tomalik-Scharte D
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):433-43. PubMed ID: 19190172
[TBL] [Abstract][Full Text] [Related]
14. Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans.
Fustinoni S; Soleo L; Warholm M; Begemann P; Rannug A; Neumann HG; Swenberg JA; Vimercati L; Colombi A
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1082-90. PubMed ID: 12376511
[TBL] [Abstract][Full Text] [Related]
15. Interest of genotyping and phenotyping of drug-metabolizing enzymes for the interpretation of biological monitoring of exposure to styrene.
Haufroid V; Jakubowski M; Janasik B; Ligocka D; Buchet JP; Bergamaschi E; Manini P; Mutti A; Ghittori S; Arand M; Hangen N; Oesch F; Hirvonen A; Lison D
Pharmacogenetics; 2002 Dec; 12(9):691-702. PubMed ID: 12464798
[TBL] [Abstract][Full Text] [Related]
16. Influence of GSTT1, mEH, CYP2E1 and RAD51 polymorphisms on diepoxybutane-induced SCE frequency in cultured human lymphocytes.
Schlade-Bartusiak K; Rozik K; Laczmanska I; Ramsey D; Sasiadek M
Mutat Res; 2004 Mar; 558(1-2):121-30. PubMed ID: 15036125
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
18. Correlation of EPHX1, GSTP1, GSTM1, and GSTT1 genetic polymorphisms with antioxidative stress markers in chronic obstructive pulmonary disease.
Lakhdar R; Denden S; Mouhamed MH; Chalgoum A; Leban N; Knani J; Lefranc G; Miled A; Ben Chibani J; Khelil AH
Exp Lung Res; 2011 May; 37(4):195-204. PubMed ID: 21309732
[TBL] [Abstract][Full Text] [Related]
19. System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk.
Zhao ZQ; Guan QK; Yang FY; Zhao P; Zhou B; Chen ZJ
Tumour Biol; 2012 Apr; 33(2):523-35. PubMed ID: 22161138
[TBL] [Abstract][Full Text] [Related]
20. Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide.
Bjellaas T; Olesen PT; Frandsen H; Haugen M; Stølen LH; Paulsen JE; Alexander J; Lundanes E; Becher G
Toxicol Sci; 2007 Jul; 98(1):110-7. PubMed ID: 17449897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
